Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine.
Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season.
“Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
Most people are deficient in vitamin D3. You can supplement with 2000, 5000, or 10,000 IU of vitamin D3 but that may not be enough. The only way to tell if your blood has an adequate amount of D3 is to have a blood test for D3 and have your doctor examine the results.
Cepsa Tower, the company's new corporate headquarters that houses almost 2,000 people, is Spain's second tallest building and represents the materialization of Cepsa's growth and internationalization strategy of in recent years, following the entry of International Petroleum Investment Company (IPIC), as sole shareholder.
The headquarters, designed by the architect Norman Foster, reflects the transformation of Cepsa's business model to focus on an increasingly international market. Its height, at 248 metres, provides a unique view of Madrid from its upper floors, taking in some of the city's most emblematic locations such as the Paseo de la Castellana, the Parque del Retiro and the Santiago Bernabéu stadium.
Cepsa today operates an integrated business model spanning the entire hydrocarbon value chain. This integration allows the company to act with greater flexibility and the ability to respond quickly as a business.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7703451-cepsa-new-headquarters-new-company/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
With America’s nursing shortage and the soaring aging population, the nation’s largest senior living provider has launched a student loan reimbursement program with the goal of attracting more nurses to work in assisted living. Brookdale’s initiative comes as the U.S. Bureau of Labor Statistics projects the country’s nurse shortfall will exceed one million by 2022. People 65 and above are expected to comprise 16 percent of America’s population in 2020 and nearly 20 percent in 2030, compared to 13 percent in 2010, according to the U.S. Census Bureau. Brookdale operates more than 1,120 senior living communities in 47 states.
At Brookdale assisted living communities, nurses are hired as health and wellness directors, overseeing clinical services at a community including setting standards, leading health and wellness programming, and managing care associates. “This is a different kind of path than hospital nursing and it is a very important one,” said Kim Estes, senior vice president of clinical services for Brookdale. “Rather than providing hands-on care, these nurses shape the overall quality and content of care their community’s seniors receive on a daily basis.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7722156-brookdale-student-loan-program-nurses/
Today, Absolut Vodka® celebrates its latest global campaign – Create a Better Tomorrow, Tonight – with the launch of The Open Mic Project. This collaborative initiative, designed in partnership with singer songwriter and actress Rita Ora, provides a platform for amplifying, and uniting, voices across the nation to refresh the talk. As a brand known for collaborating with creative forces big and small – from artists to musicians to mixologists – The Open Mic Project aligns to Absolut’s larger mission of using creativity as a force for positive change and inspiring action.
For nearly 40 years, Absolut has used nightlife, quality cocktails and creative collaborations to break down traditional barriers and forge unique connections. Now, with The Open Mic Project, Absolut is fusing these platforms together to spark a much-needed change in today’s conversation, by giving all people – regardless of background, belief or border – a voice.
To view the multimedia release go to:
https://www.multivu.com/players/English/8197551-absolut-vodka-launches-the-open-mic-project/
Movie lovers now have a new home for their favorite digital movies as Movies Anywhere launches in the U.S. today with an unprecedented five Hollywood studios and four major digital retailers on board. Featuring films from Sony Pictures Entertainment, The Walt Disney Studios (encompassing Disney, Pixar, Marvel Studios and Lucasfilm), Twentieth Century Fox Film, Universal Pictures and Warner Bros. Entertainment purchased or redeemed through digital retailers Amazon Video, Google Play, iTunes and Vudu, Movies Anywhere brings the movies people love together to create a simple, seamless digital entertainment experience across platforms.
Using the free Movies Anywhere app and website, consumers can access all their eligible movies by connecting their Movies Anywhere account with their participating digital retailer accounts. Movies Anywhere syncs users’ libraries across their connected accounts, so consumers can watch their purchased and redeemed digital movies on an array of platforms including Amazon Fire devices; Android devices and Android TV; Apple TV; Chromecast; iPhone, iPad and iPod touch; Roku® devices and popular browsers, with more platforms and retailers to come.
To view the multimedia release go to:
https://www.multivu.com/players/English/8197051-movies-anywhere-digital-movie-library/
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced the U.S. Food and Drug Administration (FDA) approval and launch of the Cochlear™ Nucleus® Hybrid Implant System, a revolutionary new hybrid hearing solution that helps people who may hear a little but are still missing a lot, even with their hearing aids. The Nucleus Hybrid System is a unique combination of proven solutions, which allows people to get back what they've been missing by amplifying the low-pitched hearing a person does have while restoring access to the high-pitched hearing they've lost. People who are candidates for the technology no longer have to worry about straining to hear with their hearing aids as the Nucleus Hybrid System will allow them to maximize their hearing in all frequencies.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7150651-cochlear-fda-approval-u-s-launch-cochlear-nucleus-hybrid-implant-system
Rowenta, maker of the revolutionary new air purifier the Intense Pure Air, is collaborating with renowned Environmental Toxicologist Dr. Noreen Khan-Mayberry (aka “The Tox Doc”), to help allergy sufferers better manage their symptoms. An estimated 50 million Americans are allergic to dust, dander, mold and mites, which can cause trouble breathing, excessive sneezing, eye irritation and coughing, amongst other ailments.
Seasonal allergies affect approximately 30% of U.S. residents and are worsening due to climate change, which is not only causing an increase in pollen levels, but also extending the length of pollen season. As such, allergy sufferers and people with asthma and other respiratory issues are at an even greater risk for heightened symptoms both indoors and outdoors.
To view the multimedia release go to:
http://www.multivu.com/players/English/7779051-rowenta-intense-allergen-air-purifier/
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision.
To view the multimedia release go to:
http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
The Mohammed bin Rashid Al Maktoum Global Initiatives and the Bill & Melinda Gates Foundation today launched a global thought leadership platform to help frame and stimulate regional and global debate on vital development issues shaping the Middle East.
The “Middle East Exchange” will commission original articles from international experts including Nobel laureates, heads of state, academics and intellectuals. New articles will be published weekly in newspapers globally on a wide range of topics relevant to the region, from health and education to development and innovation.
UAE Minister of Cabinet Affairs His Excellency Mohammed Al Gergawi discussed the project at a meeting with Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation, in Abu Dhabi on December 6. Speaking after the meeting, H.E. Al Gergawi said:
“The Middle East has spent too long in the global spotlight as a source of conflict and trouble. His Highness Sheikh Mohammed bin Rashid’s vision is for innovative and tangible solutions that benefit people’s lives on the ground. There is a huge appetite for practical ideas. The Middle East Exchange will be the number one global platform for positive voices and ideas for the Middle East.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7719851-mohammed-al-maktoum-global-initiatives/
